ChemBriefFUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Jun 17, 2026
H.B. Fuller faces uncertain future outlook due to activist pressure opposing its pursuit of Advanced Medical Solutions Group. Analysts maintain a stable fair value around $70 despite mixed views on execution risks.
2026-04-06
A Look At H.B. Fuller (FUL) Valuation After Higher Earnings And Raised 2026 Revenue Guidance2026-04-19
Does H.B. Fuller’s (FUL) Higher Dividend Payout Reveal Its True Capital Allocation Priorities?2026-04-21
The Mosaic Company Is the Most Oversold Materials Stock as Q1 Earnings Roll On (XLB:NYSEARCA)2026-04-24
HB Fuller Q1 2026 Earnings PreviewShow all 37 updates